Q3 Earnings Estimate for Nukkleus Issued By Noble Financial

Nukkleus Inc. (NASDAQ:DFNSFree Report) – Analysts at Noble Financial upped their Q3 2026 earnings estimates for Nukkleus in a report released on Wednesday, September 2nd. Noble Financial analyst J. Gomes now expects that the company will earn ($1.70) per share for the quarter, up from their prior forecast of ($2.16). Noble Financial currently has a “Strong-Buy” rating on the stock. The consensus estimate for Nukkleus’ current full-year earnings is ($3.90) per share. Noble Financial also issued estimates for Nukkleus’ Q4 2026 earnings at ($1.11) EPS and FY2027 earnings at ($4.71) EPS.

Nukkleus (NASDAQ:DFNSGet Free Report) last released its quarterly earnings data on Wednesday, August 19th. The company reported ($173.80) earnings per share for the quarter, missing the consensus estimate of ($3.11) by ($170.69). The business had revenue of $4.00 million for the quarter, compared to analysts’ expectations of $4.50 million.

Several other analysts also recently commented on the stock. Weiss Ratings downgraded shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. Wall Street Zen upgraded shares of Nukkleus from a “strong sell” rating to a “sell” rating in a report on Sunday, August 23rd. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Read Our Latest Report on DFNS

Nukkleus Price Performance

Shares of DFNS opened at $10.18 on Friday. The firm has a market cap of $16.90 million, a PE ratio of -0.03 and a beta of -5.88. The firm’s 50 day moving average price is $22.53 and its 200 day moving average price is $73.31. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.11 and a current ratio of 0.14. Nukkleus has a twelve month low of $3.70 and a twelve month high of $1,948.75.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in DFNS. BNP Paribas Financial Markets bought a new position in shares of Nukkleus in the 2nd quarter valued at approximately $56,000. UBS Group AG boosted its position in Nukkleus by 23.3% during the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after purchasing an additional 15,223 shares during the period. Ausdal Financial Partners Inc. acquired a new position in Nukkleus during the third quarter valued at approximately $105,000. Geode Capital Management LLC grew its holdings in Nukkleus by 193.7% during the fourth quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after purchasing an additional 82,252 shares during the last quarter. Finally, LPL Financial LLC acquired a new position in Nukkleus during the fourth quarter valued at approximately $120,000. Institutional investors and hedge funds own 12.47% of the company’s stock.

About Nukkleus

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Recommended Stories

Earnings History and Estimates for Nukkleus (NASDAQ:DFNS)

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.